We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $412M
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+15.49%
1 Year Est. Return
+28.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$412M
AUM Growth
+$70.8M
Cap. Flow
+$36.5M
Cap. Flow %
8.87%
Top 10 Hldgs %
4.34%
Holding
1,002
New
271
Increased
170
Reduced
168
Closed
234

Top Buys

Rank Stock Value
1
HBAN icon
Huntington Bancshares
HBAN
+$1.67M
2
DCI icon
Donaldson
DCI
+$1.6M
3
FDX icon
FedEx
FDX
+$1.6M
4
FNF icon
Fidelity National Financial
FNF
+$1.53M
5
GGG icon
Graco
GGG
+$1.51M

Top Sells

Rank Stock Value
1
CDNS icon
Cadence Design Systems
CDNS
+$1.48M
2
TIC
TIC Solutions Inc
TIC
+$1.48M
3
SDGR icon
Schrodinger
SDGR
+$1.27M
4
EXC icon
Exelon
EXC
+$1.23M
5
VC icon
Visteon
VC
+$1.22M

Sector Composition

Rank Sector Weight
1 Industrials 18.1%
2 Financials 16.8%
3 Healthcare 15.07%
4 Technology 12.86%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVVD icon
876
Invivyd
IVVD
$243M
-131,178
Closed -$171K
J icon
877
Jacobs Solutions
J
$17.1B
-4,850
Closed -$617K
KEP icon
878
Korea Electric Power
KEP
$15.3B
-17,360
Closed -$247K
KEX icon
879
Kirby Corp
KEX
$7.43B
-3,740
Closed -$497K
KOPN icon
880
Kopin
KOPN
$796M
-77,968
Closed -$175K
KR icon
881
Kroger
KR
$35.9B
-8,871
Closed -$642K
LDOS icon
882
Leidos
LDOS
$16.7B
-2,338
Closed -$364K
LIND icon
883
Lindblad Expeditions
LIND
$1.7B
-54,346
Closed -$940K
LRCX icon
884
Lam Research
LRCX
$385B
-3,047
Closed -$651K
LRMR icon
885
Larimar Therapeutics
LRMR
$398M
-44,479
Closed -$200K
LXRX icon
886
Lexicon Pharmaceuticals
LXRX
$997M
-48,498
Closed -$75.7K
LYG icon
887
Lloyds Banking Group
LYG
$88B
-38,846
Closed -$195K
M icon
888
Macy's
M
$6.06B
-16,849
Closed -$305K
MAN icon
889
ManpowerGroup
MAN
$2.88B
-7,694
Closed -$227K
MCO icon
890
Moody's
MCO
$85.5B
-559
Closed -$244K
MKSI icon
891
MKS Inc
MKSI
$17.6B
-3,289
Closed -$756K
MLAB icon
892
Mesa Laboratories
MLAB
$715M
-3,469
Closed -$307K
MMI icon
893
Marcus & Millichap
MMI
$1.21B
-19,322
Closed -$514K
MO icon
894
Altria Group
MO
$115B
-9,974
Closed -$658K
MORN icon
895
Morningstar
MORN
$7.86B
-2,387
Closed -$404K
MRNA icon
896
Moderna
MRNA
$58.1B
-6,917
Closed -$351K
MRVL icon
897
Marvell Technology
MRVL
$201B
-2,174
Closed -$215K
MTCH icon
898
Match Group
MTCH
$9.61B
-24,494
Closed -$752K
MU icon
899
Micron Technology
MU
$1.15T
-832
Closed -$281K
MUR icon
900
Murphy Oil
MUR
$5.22B
-5,687
Closed -$235K

Similar funds

EntryPoint Capital's Q2 2026 Portfolio in Review

As of Q2 2026, EntryPoint Capital held 1,002 positions worth $412M, up 21% from $341M the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.

EntryPoint Capital deployed $36.5M of net new capital in Q2 2026, opening 271 new positions and adding to 170 existing holdings. Its largest new stake was Huntington Bancshares: 101,010 shares worth $1.79M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Cadence Design Systems, an estimated $1.48M trimmed.

  • EntryPoint Capital's largest Q2 2026 buy was Huntington Bancshares: 101,010 shares worth $1.79M.
  • EntryPoint Capital added most to Gilead Sciences in Q2 2026, an estimated $1.51M increase.
  • EntryPoint Capital's biggest Q2 2026 reduction was Cadence Design Systems, cutting an estimated $1.48M.
  • EntryPoint Capital fully exited Exelon in Q2 2026, selling an estimated $1.23M.
  • EntryPoint Capital's ten largest holdings make up 4.3% of its $412M portfolio in Q2 2026.
  • EntryPoint Capital opened 271 new positions and closed 234 in Q2 2026.
  • EntryPoint Capital's portfolio value rose 21% quarter-over-quarter to $412M.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.